Patents by Inventor Claire-Lise CIANA

Claire-Lise CIANA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NOVEL COMPOUNDS
    Publication number: 20210261512
    Abstract: The present invention relates to substituted 5-membered nitrogen containing heteroaryl compounds, such as sulfonyl triazoles, where the heteroaryl ring is further substituted, optionally via a linking group such as —NH—, with a cyclic group which in turn is substituted at the ?-position. The present invention further relates to associated salts, solvates, prodrugs and pharmaceutical compositions, and to the use of such compounds in the treatment and prevention of medical disorders and diseases, most especially by NLRP3 inhibition.
    Type: Application
    Filed: May 3, 2019
    Publication date: August 26, 2021
    Applicant: INFLAZOME LIMITED
    Inventors: David MILLER, Angus MACLEOD, Stephen THOM, Christopher G. MCPHERSON, Thomas ALANINE, Jokin CARRILLO ARREGUI, Claire-Lise CIANA, Jonathan SHANNON, Jimmy VAN WILTENBURG, Jacobus Antonius Joseph DEN HARTOG
  • Acrylamide derivatives as antimalarial agents
    Patent number: 9637473
    Abstract: The invention relates to novel acrylamide derivatives of the formula I wherein R1, R2, R3, X, and ring A are as defined in the description, and their use as active ingredients in the preparation of pharmaceutical compositions. The invention also concerns related aspects including pharmaceutical compositions containing those compounds and their use as medicaments for the treatment or prevention of protozoal infections, such as especially malaria.
    Type: Grant
    Filed: March 14, 2014
    Date of Patent: May 2, 2017
    Assignee: ACTELION PHARMACEUTICALS LTD.
    Inventors: Hamed Aissaoui, Christoph Boss, Claire-Lise Ciana, Thierry Kimmerlin, Romain Siegrist
  • NOVEL ACRYLAMIDE DERIVATIVES AS ANTIMALARIAL AGENTS
    Publication number: 20160024050
    Abstract: The invention relates to novel acrylamide derivatives of the formula (I) wherein R1, R2, R3, X, and ring A are as defined in the description, and their use as active ingredients in the preparation of pharmaceutical compositions. The invention also concerns related aspects including pharmaceutical compositions containing those compounds and their use as medicaments for the treatment or prevention of protozoal infections, such as especially malaria.
    Type: Application
    Filed: March 14, 2014
    Publication date: January 28, 2016
    Applicant: ACTELION PHARMACEUTICALS LTD
    Inventors: Hamed AISSAOUI, Christoph BOSS, Claire-Lise CIANA, Thierry KIMMERLIN, Romain SIEGRIST